定位手術装置の世界市場：洞察、競合情勢、市場予測：2030年

世界の定位手術装置の市場規模は、2024年から2030年までの予測期間中に5.37％のCAGRで拡大すると予測されています。定位手術装置市場は、いくつかの相互関連的な要因によって大きな成長を遂げています。まず、脳腫瘍、パーキンソン病、てんかんといった神経疾患の有病率の上昇により、定位手術装置が提供できる精密な外科的介入に対する需要が高まっています。さらに、回復時間の短縮や合併症発生率の低下といった利点から、低侵襲手術の採用が増加しています。さらに、主な市場開拓企業による継続的な製品開発活動により、定位手術装置の機能や特徴が強化され、手術結果や患者の安全性を向上させる技術革新が進み、2024年から2030年までの予測期間中の市場成長をさらに後押ししています。

さらに、世界保健機関（WHO）の最新データ（2024年）によると、てんかんは世界で約5,000万人が罹患しており、世界的に最も蔓延している神経疾患の1つです。罹患者の80％近くが中低所得国に居住しています。

このような神経疾患が蔓延するにつれ、それらを管理・治療するための正確で効果的な外科的ソリューションに対する需要が高まっています。定位手術装置は、脳腫瘍の正確な標的化と治療、てんかん発作の制御、脳卒中関連の合併症への対処において極めて重要な役割を果たしています。最小限の侵襲で標的治療を行うその能力は、治療結果を向上させ、回復時間を短縮します。その結果、症例数の増加により高度な手術技術が必要となり、世界中で定位装置の需要を牽引しています。

しかし、感染、出血、麻酔の副作用など定位手術装置に関連するリスクや、製品承認のための厳しい規制上の懸念が定位手術装置の成長を妨げる可能性があります。

当レポートでは、世界の定位手術装置市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別動向、競合情勢、国別動向などを提供しています。

目次

第1章 定位手術装置市場レポートのイントロダクション

第2章 定位手術装置市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 定位手術装置市場の主な要因分析

• 定位手術装置市場の促進要因
• 定位手術装置市場の抑制要因と課題
• 定位手術装置市場の機会

第6章 定位手術装置市場のポーターのファイブフォース分析

第7章 定位手術装置市場評価

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 定位手術装置市場の企業と製品プロファイル

• Elekta AB
• Accuray Incorporated
• Ion Beam Applications S.A.
• Mevion Medical Systems
• Varian Medical Systems, Inc. (Siemens Healthineers)
• inomed Medizintechnik GmbH
• adeor medical AG
• Bramsys Industria e Comercio Ltd.
• Micromar Ind. E Com. LTDA
• Mizuho Medical Co. Ltd.
• Shinva Medical Instrument Co.,ltd.
• Panacea Medical Technologies Pvt. Ltd.
• Sumitomo Heavy Industries, Ltd.
• Hitachi Co. Ltd.
• ClearPoint Neuro

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Stereotactic Surgery Devices Market in Global (2021-2030)
• Table 3: Stereotactic Surgery Devices Market in Global by Product Type (2021-2030)
• Table 4: Stereotactic Surgery Devices Market in Global by End-User (2021-2030)
• Table 5: Stereotactic Surgery Devices Market in Global by Geography (2021-2030)
• Table 6: Stereotactic Surgery Devices Market in North America (2021-2030)
• Table 7: Stereotactic Surgery Devices Market in the United States (2021-2030)
• Table 8: Stereotactic Surgery Devices Market in Canada (2021-2030)
• Table 9: Stereotactic Surgery Devices Market in Mexico (2021-2030)
• Table 10: Stereotactic Surgery Devices Market in Europe (2021-2030)
• Table 11: Stereotactic Surgery Devices Market in France (2021-2030)
• Table 12: Stereotactic Surgery Devices Market in Germany (2021-2030)
• Table 13: Stereotactic Surgery Devices Market in United Kingdom (2021-2030)
• Table 14: Stereotactic Surgery Devices Market in Italy (2021-2030)
• Table 15: Stereotactic Surgery Devices Market in Spain (2021-2030)
• Table 16: Stereotactic Surgery Devices Market in the Rest of Europe (2021-2030)
• Table 17: Stereotactic Surgery Devices Market in Asia-Pacific (2021-2030)
• Table 18: Stereotactic Surgery Devices Market in China (2021-2030)
• Table 19: Stereotactic Surgery Devices Market in Japan (2021-2030)
• Table 20: Stereotactic Surgery Devices Market in India (2021-2030)
• Table 21: Stereotactic Surgery Devices Market in Australia (2021-2030)
• Table 22: Stereotactic Surgery Devices Market in South Korea (2021-2030)
• Table 23: Stereotactic Surgery Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Stereotactic Surgery Devices Market in the Rest of the World (2021-2030)
• Table 25: Stereotactic Surgery Devices Market in the Middle East (2021-2030)
• Table 26: Stereotactic Surgery Devices Market in Africa (2021-2030)
• Table 27: Stereotactic Surgery Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Stereotactic Surgery Devices Market in Global (2021-2030)
• Figure 3: Stereotactic Surgery Devices Market in Global by Product Type (2021-2030)
• Figure 4: Stereotactic Surgery Devices Market in Global by End-User (2021-2030)
• Figure 5: Stereotactic Surgery Devices Market in Global by Geography (2021-2030)
• Figure 6: Stereotactic Surgery Devices Market in North America (2021-2030)
• Figure 7: Stereotactic Surgery Devices Market in the United States (2021-2030)
• Figure 8: Stereotactic Surgery Devices Market in Canada (2021-2030)
• Figure 9: Stereotactic Surgery Devices Market in Mexico (2021-2030)
• Figure 10: Stereotactic Surgery Devices Market in Europe (2021-2030)
• Figure 11: Stereotactic Surgery Devices Market in France (2021-2030)
• Figure 12: Stereotactic Surgery Devices Market in Germany (2021-2030)
• Figure 13: Stereotactic Surgery Devices Market in United Kingdom (2021-2030)
• Figure 14: Stereotactic Surgery Devices Market in Italy (2021-2030)
• Figure 15: Stereotactic Surgery Devices Market in Spain (2021-2030)
• Figure 16: Stereotactic Surgery Devices Market in the Rest of Europe (2021-2030)
• Figure 17: Stereotactic Surgery Devices Market in Asia-Pacific (2021-2030)
• Figure 18: Stereotactic Surgery Devices Market in China (2021-2030)
• Figure 19: Stereotactic Surgery Devices Market in Japan (2021-2030)
• Figure 20: Stereotactic Surgery Devices Market in India (2021-2030)
• Figure 21: Stereotactic Surgery Devices Market in Australia (2021-2030)
• Figure 22: Stereotactic Surgery Devices Market in South Korea (2021-2030)
• Figure 23: Stereotactic Surgery Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Stereotactic Surgery Devices Market in the Rest of the World (2021-2030)
• Figure 25: Stereotactic Surgery Devices Market in the Middle East (2021-2030)
• Figure 26: Stereotactic Surgery Devices Market in Africa (2021-2030)
• Figure 27: Stereotactic Surgery Devices Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER'S Five Force Analysis

Stereotactic Surgery Devices Market by Product Type (Gamma Knife, Linear Particle Accelerators, Proton Therapy Systems, and Stereotactic Systems), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of neurological disorders, increasing adoption of minimally invasive procedures, and increase in product development activities by the key market players across the globe.

The global stereotactic surgery devices market is projected to grow at a 5.37% CAGR during the forecast period from 2024 to 2030. The market for stereotactic surgery devices is experiencing significant growth due to several interconnected factors. Firstly, the rising prevalence of neurological conditions such as brain tumors, Parkinson's disease, and epilepsy has increased the demand for precise surgical interventions that stereotactic devices can offer. Additionally, there is a growing adoption of minimally invasive procedures, driven by their benefits of reduced recovery times and lower complication rates. Furthermore, the ongoing product development activities by the key market players are enhancing the capabilities and features of stereotactic devices, leading to innovations that improve surgical outcomes and patient safety further propelling the market growth during forecast period from 2024 to 2030.

Stereotactic Surgery Devices Market Dynamics:

According to the recent data provided by the GLOBOCAN, in 2022, globally the estimated new cases of brain and central nervous system cancer was estimated to be 322,000 per 100,000 population and the projection were estimated to increase 474,000 per 100,000 population by 2045.

Additionally, as per the recent data provided by the World Health Organization (2024), epilepsy affects approximately 50 million people worldwide, making it one of the most prevalent neurological disorders globally. Nearly 80% of those affected reside in low- and middle-income countries.

As these neurological conditions become more prevalent, there is an increased demand for precise and effective surgical solutions to manage and treat them. Stereotactic surgery devices play a pivotal role in accurately targeting and treating brain tumors, controlling epileptic seizures, and addressing stroke-related complications. Their ability to deliver targeted therapy with minimal invasiveness enhances treatment outcomes and reduces recovery times. Consequently, the growing number of cases necessitates advanced surgical technologies, driving the demand for stereotactic devices across the globe.

Along with the factors mentioned above, technological advancements in the field of stereotactic surgery devices such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the stereotactic surgery devices market. For instance, in June 2021, NaviNetics Inc. received the premarket product approval from the US Food and Drug Administration for their NaviNeticsD1 stereotactic system.

However, the risk associated with stereotactic surgery device such as infection, bleeding, or adverse reactions to anesthesia, and stringent regulatory concerns for product approval may hinder the growth of stereotactic surgery devices.

Stereotactic Surgery Devices Market Segment Analysis:

Stereotactic Surgery Devices Market by Product Type (Gamma Knife, Linear Particle Accelerators, Proton Therapy Systems, and Stereotactic Systems), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall stereotactic surgery devices market, the proton therapy system are expected to hold the largest share in the year 2023. Proton therapy, known for its precision and reduced collateral damage to surrounding healthy tissues, complements stereotactic surgery's focus on high-accuracy interventions. The integration of proton therapy systems into cancer treatment regimens highlights the need for advanced stereotactic devices to precisely target tumors and optimize therapeutic outcomes. Proton therapy's ability to deliver high doses of radiation with minimal exposure to healthy tissues supports the growing trend toward personalized and targeted cancer treatments, which, in turn, fuels the demand for stereotactic surgery systems that can accurately guide and monitor such therapies.

Additionally, the technological advancements driven by proton therapy innovations, fostering a competitive market environment that spurs continuous improvement and expansion. For instance, in October 2021, Ion Beam Applications SA announced the launch of the first online platform dedicated to proton therapy.

Hence, all the above-mentioned factors are expected to boost the growth of the segment, thus generating a considerable revenue for Proton Therapy Systems during the forecast period.

North America is expected to dominate the overall stereotactic surgery devices market:

Among all the regions, North America is expected to hold the largest share in the global Stereotactic Surgery Devices market in 2023. The growing prevalence of traumatic brain injuries, neurological disorders such as epilepsy, Alzheimer's, and Parkinson's disease across the region is escalating the overall market of stereotactic surgery across the region. Additionally, recent product developmental activities, and rising government initiatives are expected to aid in the growth of the North American stereotactic surgery devices market during the forecast period from 2024 to 2030.

According, to the recent data provided by the Centre for Disease Control and Prevention (2024), in 2021, about 2.9 million adults 18 and older reported having active epilepsy in the United States

Furthermore, as per the recent data provided by Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the United States.

Additionally, as per the recent data provided by the Alzheimer's Association, in 2024, approximately 6.9 million Americans age 65 and older are living with Alzheimer's.

Furthermore, as per the recent data provided by the Parkinson's Foundation (2022), nearly 90,000 people are diagnosed with Parkinson's disease in the U.S. each year and approximately one million people in the U.S. are living with Parkinson's disease (PD). This number is expected to rise to 1.2 million by 2030.

These complex neurological disorders often require highly accurate surgical interventions to manage symptoms, improve outcomes, and enhance quality of life. Stereotactic surgery devices, known for their precision in targeting specific brain regions, are essential for treating these conditions effectively. The rising incidence of these disorders and the demand for minimally invasive surgical techniques are leading to greater adoption of stereotactic devices, which are crucial for accurate diagnostics, treatment planning, and real-time adjustments during surgery thus, escalating the market across the region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for stereotactic surgery devices. For instance, in June 2021, Elekta AB received the product approval from the US FDA for their linear accelerator-based Elekta harmony radiation therapy system.

Therefore, the interplay of above mentioned various factors in the region are expected to boost the North America stereotactic surgery devices market during the forecast period.

Stereotactic Surgery Devices Market Key Players:

Some of the key market players operating in the stereotactic surgery devices market include Elekta AB, Accuray Incorporated, Ion Beam Applications S.A., Mevion Medical Systems, Varian Medical Systems, Inc. (Siemens Healthineers), inomed Medizintechnik GmbH, adeor medical AG, Bramsys Industria e Comercio Ltd., Micromar Ind. E Com. LTDA, Mizuho Medical Co. Ltd., Shinva Medical Instrument co.,ltd., Panacea Medical Technologies Pvt. Ltd., Sumitomo Heavy Industries, Ltd., Hitachi Co. Ltd., ClearPoint Neuro, and others.

Recent Developmental Activities in the Stereotactic Surgery Devices Market:

• In July 2024, Apollo Cancer Centres collaborated with Accuray to launch Indian sub- continent's first robotic stereotactic radiotherapy program.
• In January 2024, ClearPoint Neuro announced the FDA clearance for SmartFrame OR(TM) stereotactic system.

Key Takeaways From the Stereotactic Surgery Devices Market Report Study:

• Market size analysis for current stereotactic surgery devices size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the stereotactic surgery devices market.
• Various opportunities available for the other competitors in the stereotactic surgery devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current stereotactic surgery devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for stereotactic surgery devices market growth in the coming future?

Target Audience who can be Benefited From This Stereotactic Surgery Devices Market Report Study:

• Stereotactic surgery devices product providers
• Research organizations and consulting companies
• Stereotactic surgery devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in stereotactic surgery devices
• Various end-users who want to know more about the stereotactic surgery devices market and the latest technological developments in the stereotactic surgery devices market.

Frequently Asked Questions for the Stereotactic Surgery Devices Market:

1. What are stereotactic surgery devices?

• Stereotactic surgery devices are specific devices that are used in the performance of stereotactic radiosurgery and radiotherapy such as proton systems and LINACs.

2. What is the market for stereotactic surgery devices?

• The global stereotactic surgery devices market is projected to grow at a 5.37% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the stereotactic surgery devices market?

• The market for stereotactic surgery devices is experiencing significant growth due to several interconnected factors. Firstly, the rising prevalence of neurological conditions such as brain tumours, Parkinson's disease, and epilepsy has increased the demand for precise surgical interventions that stereotactic devices can offer. Additionally, there is a growing adoption of minimally invasive procedures, driven by their benefits of reduced recovery times and lower complication rates. Furthermore, the ongoing product development activities by key market players are enhancing the capabilities and features of stereotactic devices, leading to innovations that improve surgical outcomes and patient safety further propelling the market growth during forecast period from 2024 to 2030.

4. Who are the key players operating in the stereotactic surgery devices market?

• Some of the key market players operating in the stereotactic surgery devices market include Elekta AB, Accuray Incorporated, Ion Beam Applications S.A., Mevion Medical Systems, Varian Medical Systems, Inc. (Siemens Healthineers), inomed Medizintechnik GmbH, adeor medical AG, Bramsys Industria e Comercio Ltd., Micromar Ind. E Com. LTDA, Mizuho Medical Co. Ltd., Shinva Medical Instrument co.,ltd., Panacea Medical Technologies Pvt. Ltd., Sumitomo Heavy Industries, Ltd., Hitachi Co. Ltd., ClearPoint Neuro, and others.

5. Which region has the highest share in the stereotactic surgery devices market?

• Among all the regions, North America is expected to hold the largest share in the global stereotactic surgery devices market in 2023. The growing prevalence of traumatic brain injuries, neurological disorders such as epilepsy, Alzheimer's, and Parkinson's disease across the region is escalating the overall market of neurological diagnostic and monitoring equipment across the region. Additionally, recent product developmental activities, and rising government initiatives are expected to aid in the growth of the North American stereotactic surgery devices market during the forecast period from 2024 to 2030.

Table of Contents

1. Stereotactic Surgery Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Stereotactic Surgery Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Stereotactic Surgery Devices Market Key Factors Analysis

• 5.1. Stereotactic Surgery Devices Market Drivers
  • 5.1.1. Increasing prevalence of neurological disorders
  • 5.1.2. Growing adoption of minimally invasive techniques
  • 5.1.3. Increase in product development activities by key market players across the globe
• 5.2. Stereotactic Surgery Devices Market Restraints and Challenges
  • 5.2.1. Risk associated with stereotactic surgery devices such as bleeding, infection, and others
  • 5.2.2. Stringent regulatory concerns for product approval
• 5.3. Stereotactic Surgery Devices Market Opportunities
  • 5.3.1. Integration of proton beam therapy and robotic assisted surgeries

6. Stereotactic Surgery Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Stereotactic Surgery Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Gamma Knife
  • 7.1.2. Linear Particle Accelerators
  • 7.1.3. Proton Therapy Systems
  • 7.1.4. Stereotactic Systems
• 7.2. By End-User
  • 7.2.1. Hospitals
  • 7.2.2. Ambulatory Surgical Centers
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.1.2. Canada Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.1.3. Mexico Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.2.2. Germany Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.2.3. United Kingdom Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.2.4. Italy Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.2.5. Spain Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.2.6. Rest of Europe Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.3.2. Japan Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.3.3. India Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.3.4. Australia Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.3.5. South Korea Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.4.2. Africa Stereotactic Surgery Devices Market Size in USD Million (2021-2030)
    • 7.3.4.3. South America Stereotactic Surgery Devices Market Size in USD Million (2021-2030)

8. Stereotactic Surgery Devices Market Company and Product Profiles

• 8.1. Elekta AB
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Accuray Incorporated
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Ion Beam Applications S.A.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Mevion Medical Systems
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Varian Medical Systems, Inc. (Siemens Healthineers)
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. inomed Medizintechnik GmbH
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. adeor medical AG
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Bramsys Industria e Comercio Ltd.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Micromar Ind. E Com. LTDA
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Mizuho Medical Co. Ltd.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Shinva Medical Instrument Co.,ltd.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Panacea Medical Technologies Pvt. Ltd.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Sumitomo Heavy Industries, Ltd.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Hitachi Co. Ltd.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. ClearPoint Neuro
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us